Literature DB >> 28905689

IgG4-Related Cholangiopathy and Its Mimickers: A Case Report and Review Highlighting the Importance of Early Diagnosis.

Kyle Geary1, Cemal Yazici1, Anita Seibold2, Grace Guzman1.   

Abstract

Immunoglobulin (Ig) G4 (IgG4)-related disease is a recently described clinical entity that can involve multiple organs. It is an autoimmune disorder characterized by a dense lymphoplasmacytic infiltrate, storiform fibrosis, and obliterative phlebitis. A key distinguishing factor is its dramatic response to steroid therapy. Although best described in cases of autoimmune pancreatitis, IgG4-related disease has also been implicated in patients with cholangitis and is now commonly referred to as IgG4-related cholangiopathy. It is characterized by elevated serum IgG4 levels, an IgG4-positive plasma cell infiltration with storiform fibrosis/obliterative phlebitis of the bile duct wall, and a response to steroids. It is crucial to differentiate IgG4-related cholangiopathy from its mimickers, such as primary biliary cholangitis, secondary biliary cholangitis, primary sclerosing cholangitis, secondary sclerosing cholangitis, and cholangiocarcinoma, because treatment modalities and outcomes of IgG4-related cholangiopathy differ significantly from these disorders. Here, we present an interesting case of IgG4-related cholangiopathy, discuss clinical and pathological features crucial to its early diagnosis, and compare and contrast this condition with its potentially confounding mimickers.

Entities:  

Keywords:  IgG4-associated cholangiopathy; IgG4-related disease; diagnosis; steroids

Mesh:

Substances:

Year:  2017        PMID: 28905689     DOI: 10.1177/1066896917730902

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  1 in total

1.  A good response to steroid therapy in IgG4-related sclerosing cholangitis: a case report.

Authors:  Jingqiao Zhang; Xiaozhong Guo; Hongyu Li; Xiaodong Shao; Jiao Deng; Zhendong Liang; Xia Zhang; Ji Feng; Hao Lin; Xingshun Qi
Journal:  Clin Exp Hepatol       Date:  2018-09-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.